semaglutide for weight loss phoenix Oral Tirzepatide Semaglutide GLP-1 for Medical Weight

OTCQX: RHHBY) announced today positive topline results from two arms of an ongoing multi-part Phase I clinical trial for CT-996, an investigational, once-daily, oral small molecule GLP-1 receptor agonist being developed for the treatment of both type 2 diabetes and obesity

For the best results, its recommended to pair it with the tried-and-true duo of a healthy diet and regular exercise

Together, well help you build realistic, sustainable habits that fit your lifenot a restrictive diet that feels impossible to maintain

These two pathways are additive

As a signaling molecule, GLP-1 increases the bodys sensitivity to insulin, the hormone responsible for controlling blood sugar levels